TIGIT and melanoma: TIGIT-deficient mice show significantly delayed tumour growth in distinct murine models [19]; however, the number of pulmonary metastatic deposits was comparable following B16 melanoma cell inoculation in TIGIT-deficient and wild-type mice [16, 20].